Enbridge’s sensible leverage, growth outlook, and potential for 12% returns make it compelling. Read why ENB stock is a buy.

Relay Therapeutics gains capital via licensing, reduces costs, and advances its promising PI3K-alpha inhibitor. See why RLAY ...

Start selling your clothes online. The side hustle that doesn't require much time, or a special skill. The pandemic closet ...

President Donald Trump has authorized the military to take control of lands along the U.S.-Mexico border - leading a top ...

Former Treasury Secretary Janet Yellen weighed in on the Trump administration’s trade war Friday evening, blasting President ...

Rep. Jasmine Crockett (D-Texas) railed against President Trump late Thursday, questioning his mental fitness amid economic ...

Russia and Ukraine’s top diplomats on Saturday used a high-level conference in Turkey to once again trade accusations of ...

A dozen former OpenAI employees filed a legal brief on Friday backing co-founder Elon Musk's lawsuit aimed at keeping the non ...

Democrats are quick to say that President Donald Trump’s tariffs are horrible, awful, terrible. But Democrats are also ...

Robert Mueller and Jack Smith investigated Trump for the DOJ on questions of obstruction of justice, election interference ...

Petterson’s dropoff since his 102-point season in 2022-23 has been jarring to watch, and even if he’s dealing with injuries ...